Silexion Therapeutics receives Nasdaq delisting notice; plans appeal

Silexion Therapeutics Corp

Received delisting notice on May 22, 2025 for MVLS <$50M and MVPHS <$15M non-compliance.
Failed to regain compliance within 180-day period ending May 19, 2025.
Intends to appeal by May 29, 2025; trading suspension effective June 2, 2025 if appeal fails.
Plans to request transfer to Nasdaq Capital Market; requires at least $2.5M shareholders' equity.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.